207 related articles for article (PubMed ID: 12230841)
1. Intellectual property and products of nature.
Sagoff M
Am J Bioeth; 2002; 2(3):12-3. PubMed ID: 12230841
[No Abstract] [Full Text] [Related]
2. How can you patent genes?
Eisenberg RS
Am J Bioeth; 2002; 2(3):3-11. PubMed ID: 12230840
[TBL] [Abstract][Full Text] [Related]
3. No patents for semantic information.
Wilson J
Am J Bioeth; 2002; 2(3):15-6. PubMed ID: 12230843
[No Abstract] [Full Text] [Related]
4. Sequence patents are not the issue.
Robertson JA
Am J Bioeth; 2002; 2(3):22-3. PubMed ID: 12230848
[No Abstract] [Full Text] [Related]
5. The two meanings of how and the gene patenting debate.
Evans JH
Am J Bioeth; 2002; 2(3):26-8. PubMed ID: 12230851
[No Abstract] [Full Text] [Related]
6. Genes and patent policy: rethinking intellectual property rights.
Andrews LB
Nat Rev Genet; 2002 Oct; 3(10):803-8. PubMed ID: 12360238
[TBL] [Abstract][Full Text] [Related]
7. Locating gene patents within the patent system.
Rai AK
Am J Bioeth; 2002; 2(3):18-9. PubMed ID: 12230845
[No Abstract] [Full Text] [Related]
8. Intellectual property and biotechnology: the U.S. internal experience--Part II.
Brody B
Kennedy Inst Ethics J; 2006 Jun; 16(2):105-28. PubMed ID: 17036443
[TBL] [Abstract][Full Text] [Related]
9. Diagnostics firms face new patent claim worries.
Allison M
Nat Biotechnol; 2009 Jul; 27(7):586-7. PubMed ID: 19587651
[No Abstract] [Full Text] [Related]
10. Intellectual property. Patents, secrecy, and DNA.
Cook-Deegan RM; McCormack SJ
Science; 2001 Jul; 293(5528):217. PubMed ID: 11452101
[No Abstract] [Full Text] [Related]
11. Enforcing pharmaceutical and biotech patent rights in China.
Zhang YP; Deng MM
Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
[No Abstract] [Full Text] [Related]
12. DNA-based patents: an empirical analysis.
Mills AE; Tereskerz P
Nat Biotechnol; 2008 Sep; 26(9):993-5. PubMed ID: 18779808
[TBL] [Abstract][Full Text] [Related]
13. The Supreme Court's war on intellectual property.
Gardner JN
Nat Biotechnol; 2000 Jan; 18(1):101-2. PubMed ID: 10625402
[TBL] [Abstract][Full Text] [Related]
14. Waiting on science: the stake of present and future patients.
Quigley RB
Am J Bioeth; 2002; 2(3):17-8. PubMed ID: 12230844
[No Abstract] [Full Text] [Related]
15. Patenting DNA: who defines and protects the public good?
Garcia SA
Am J Bioeth; 2002; 2(3):25-6. PubMed ID: 12230850
[No Abstract] [Full Text] [Related]
16. Intellectual property. Enhanced: intellectual property landscape of the human genome.
Jensen K; Murray F
Science; 2005 Oct; 310(5746):239-40. PubMed ID: 16224006
[TBL] [Abstract][Full Text] [Related]
17. Bayh-Dole: if we knew then what we know now.
Boettiger S; Bennett AB
Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405
[No Abstract] [Full Text] [Related]
18. The unexamined assumptions of intellectual property: adopting an evaluative approach to patenting biotechnological innovation.
Gold ER; Adams W; Castle D; de Langavant GC; Cloutier LM; Daar AS; Glass A; Smith PJ; Bernier L
Public Aff Q; 2004 Oct; 18(4):299-344. PubMed ID: 15812959
[No Abstract] [Full Text] [Related]
19. Intellectual property rights in agriculture in the light of the debate on biotechnology: historical evolution and current situation.
Gimelli F
Ital J Biochem; 2000; 49(3-4):41-51. PubMed ID: 11508056
[No Abstract] [Full Text] [Related]
20. Ethico-legal issues in biomedicine patenting: a patent professional viewpoint.
Crespi RS
Sci Eng Ethics; 2005 Jan; 11(1):117-36. PubMed ID: 15727007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
